Insights

Strategic Acquisition Leverage the recent Ginkgo Bioworks acquisition to approach Proof Diagnostics as a strategic fit for integrated gene editing services and CRISPR-based diagnostics capabilities, exploring co-development or continued collaboration post-acquisition.

Point-of-Care Ramp Target healthcare facilities, pharmacies, schools and workplaces with Proof’s CRISPR-RT-LAMP based test platform for rapid on-site SARS-CoV-2 testing, offering a turnkey solution that reduces result wait times and operational burden.

Home Diagnostics Path Position opportunities around the planned shift to home-based diagnostics by offering scalable, user-friendly kits, data connectivity, and remote support services to extend the platform beyond clinics to consumer health management.

Quality and Compliance Highlight ISO certifications (ISO 13485, ISO 14971) and regulatory readiness as a differentiator when engaging potential buyers in regulated environments such as hospitals, clinics and education facilities.

Funding and Growth Capitalize on a $45M funding runway and a high-profile founder network to propose multi-phase pilots, bundled services, and potential co-investment opportunities with customers seeking innovative diagnostics acceleration.

Proof Diagnostics, Inc. Tech Stack

Proof Diagnostics, Inc. uses 8 technology products and services including RT-qPCR, ISO 13485, ISO, and more. Explore Proof Diagnostics, Inc.'s tech stack below.

  • RT-qPCR
    Analytics
  • ISO 13485
    Certificates
  • ISO
    Certificates
  • Amazon Web Services
    Cloud Hosting
  • Microsoft Excel
    Editors
  • jQuery
    Javascript Libraries
  • Python
    Programming Languages
  • ISO 14971
    Risk And Compliance

Proof Diagnostics, Inc.'s Email Address Formats

Proof Diagnostics, Inc. uses at least 1 format(s):
Proof Diagnostics, Inc. Email FormatsExamplePercentage
First@proofdx.comJohn@proofdx.com
100%

Frequently Asked Questions

What is Proof Diagnostics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Proof Diagnostics, Inc.'s official website is proofdx.com and has social profiles on LinkedInCrunchbase.

How much revenue does Proof Diagnostics, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, Proof Diagnostics, Inc.'s annual revenue is estimated to be <$1M.

What is Proof Diagnostics, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Proof Diagnostics, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Proof Diagnostics, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Proof Diagnostics, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Associate Director, Computational Biology: A. G.Laboratory Operations Manager: A. C.Laboratory Operations Manager: A. C.. Explore Proof Diagnostics, Inc.'s employee directory with LeadIQ.

What industry does Proof Diagnostics, Inc. belong to?

Minus sign iconPlus sign icon
Proof Diagnostics, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does Proof Diagnostics, Inc. use?

Minus sign iconPlus sign icon
Proof Diagnostics, Inc.'s tech stack includes RT-qPCRISO 13485ISOAmazon Web ServicesMicrosoft ExceljQueryPythonISO 14971.

What is Proof Diagnostics, Inc.'s email format?

Minus sign iconPlus sign icon
Proof Diagnostics, Inc.'s email format typically follows the pattern of First@proofdx.com. Find more Proof Diagnostics, Inc. email formats with LeadIQ.

How much funding has Proof Diagnostics, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Proof Diagnostics, Inc. has raised $45M in funding. The last funding round occurred on Apr 07, 2022 for $45M.

When was Proof Diagnostics, Inc. founded?

Minus sign iconPlus sign icon
Proof Diagnostics, Inc. was founded in 2020.
Proof Diagnostics, Inc. logo

Proof Diagnostics, Inc.

Medical Equipment ManufacturingMassachusetts, United States0-1 Employees

Proof Diagnostics, Inc. is a medical equipment manufacturing company based in Cambridge, Massachusetts, United States, employing 11-50 people, and operating a website at proofdx.com. It operates as a health technology and diagnostics company developing a CRISPR-based platform for point-of-care testing of SARS-CoV-2, with aims to expand into in-home diagnostics across a broader range of health applications. The company traces its origins to work led by Professor Feng Zhang and colleagues who pivoted their efforts toward addressing the COVID-19 pandemic in early 2020. The platform combines CRISPR and RT-LAMP technologies to enable a simple, streamlined molecular diagnostic test intended for use in clinics, pharmacies, schools, workplaces, and eventually homes. In February 2024, Ginkgo Bioworks acquired Proof Diagnostics, integrating its capabilities into its broader gene editing service offerings.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2020
Employees
0-1

Section iconFunding & Financials

  • $45M

    Proof Diagnostics, Inc. has raised a total of $45M of funding over 2 rounds. Their latest funding round was raised on Apr 07, 2022 in the amount of $45Mas a series_a.

  • <$1M

    Proof Diagnostics, Inc.'s revenue is estimated to be in the range of <$1M

Section iconFunding & Financials

  • $45M

    Proof Diagnostics, Inc. has raised a total of $45M of funding over 2 rounds. Their latest funding round was raised on Apr 07, 2022 in the amount of $45Mas a series_a.

  • <$1M

    Proof Diagnostics, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.